The latest iteration of Vitrea 2, Vital Images' 3D visualization and analysis software for CT and MR, is out. The company has begun shipping the new software to initial customers and installed Vitrea 2 sites. Version 3.1 offers advances in CT
The latest iteration of Vitrea 2, Vital Images' 3D visualization and analysis software for CT and MR, is out. The company has begun shipping the new software to initial customers and installed Vitrea 2 sites. Version 3.1 offers advances in CT colonography that promise to increase productivity and shorten reading times. The new version also introduces the Study Viewer, which supports the visualization of data while a patient is being scanned.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.